These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18327448)

  • 21. [Analysis of records for women that have undergone legally authorized abortions in Porto Alegre, Rio Grande do Sul State, Brazil].
    Silva MCBD; Knauth DR; Borges RB; Nunes LN; Giugliani C
    Cad Saude Publica; 2021; 37(11):e00282920. PubMed ID: 34816958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Obstetrical inpatient care and hospitalization risks in hospitals of Brazil].
    Schramm JM; Szwarcwald CL; Esteves MA
    Rev Saude Publica; 2002 Oct; 36(5):590-7. PubMed ID: 12471384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of the Hospital Information System for maternal mortality surveillance in Brazil.
    Ranzani OT; Marinho MF; Bierrenbach AL
    Rev Bras Epidemiol; 2023; 26():e230007. PubMed ID: 36629619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomics-based study on the significance of differential metabolite binding IgG isoforms in Hemolytic disease of newborn.
    Zhang S; Li S; Meng X; Chen J; Tang Y; Li X
    Hematology; 2024 Dec; 29(1):2360339. PubMed ID: 38828919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-invasive fetal RHD and RHCE genotyping from maternal plasma in alloimmunized pregnancies.
    Hromadnikova I; Vesela K; Benesova B; Nekovarova K; Duskova D; Vlk R; Spalova I; Gerychova R; Hakenova A; Rosenbaumova Z; Vlasin P; Vlachova A; Palasek V; Roznakova E; Calda P
    Prenat Diagn; 2005 Dec; 25(12):1079-83. PubMed ID: 16231295
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe hemolytic disease of the newborn from anti-e.
    McAdams RM; Dotzler SA; Winter LW; Kerecman JD
    J Perinatol; 2008 Mar; 28(3):230-2. PubMed ID: 18309317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Detection and analysis of ABO Hemolytic disease in newborn].
    Lin ZX; Dong QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1432-4. PubMed ID: 25338602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of Fc(gamma)RIIa (CD32) Polymorphism and IgG Antibody Subclasses in Hemolytic Disease of Newborn.
    Wu Q; Zhang Y; Liu M; Wang B; Liu S; He C
    Neonatology; 2009; 96(1):1-5. PubMed ID: 19129718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical analysis of seven cases of rare hemolytic disease of the newborn].
    Gu S; Wang HX; Yang CY; Yang XF; Lin Y; Zhong Y; He JP; Wang YJ
    Zhonghua Er Ke Za Zhi; 2018 May; 56(5):369-372. PubMed ID: 29783824
    [No Abstract]   [Full Text] [Related]  

  • 30. Two years' experience with Rh hemolytic disease reporting.
    Hawes WE; Mordaunt VL
    Calif Med; 1973 May; 118(5):28-32. PubMed ID: 4633598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PCR-based determination of Rhc and RhE status of fetuses at risk of Rhc and RhE haemolytic disease.
    Le Van Kim C; Mouro I; Brossard Y; Chavinié J; Cartron JP; Colin Y
    Br J Haematol; 1994 Sep; 88(1):193-5. PubMed ID: 7803243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical significance of anti-D IgG screening and titer detection in 286 RhD negative pregnant women].
    Liu KL; Li N; Li BJ; Peng JY; Shu XW; Yu YY
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):185-7. PubMed ID: 19292952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Analysis of Screening Results in 501 Newborns with Hemolytic Disease].
    Ma X; Chen FZ; Hong Q
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):192-196. PubMed ID: 30738469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laboratory identification of erythroblastosis fetalis.
    Kurtz EM; Pappas AA; Cannon A
    Ann Clin Lab Sci; 1982; 12(5):388-97. PubMed ID: 6814344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Quality of birth defect reporting in the Brazilian Information System on Live Births (SINASC): a comparative study of 2004 and 2007].
    Luquetti DV; Koifman RJ
    Cad Saude Publica; 2010 Sep; 26(9):1756-65. PubMed ID: 20877936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unusually severe ABO hemolytic disease of newborn.
    Goraya J; Basu S; Sodhi P; Mehta S
    Indian J Pediatr; 2001 Mar; 68(3):285-6. PubMed ID: 11338229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RHD zygosity assignments based on most probable genotype and hybrid Rhesus box detection in Tunisia.
    Kacem N; Chakroun T; Moussa H; Abdelkefi S; Houissa B; Chiaroni J; Jemni Yacoub S
    Transfus Med; 2012 Oct; 22(5):362-6. PubMed ID: 22757646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Current status of neonatal hemolytic disease caused by Rh incompatibility].
    Uhlig R; Menzel K
    Z Arztl Fortbild (Jena); 1986; 80(4):143-8. PubMed ID: 3087070
    [No Abstract]   [Full Text] [Related]  

  • 40. [Recombinant erythropoietin as treatment for hyporegenerative anemia following hemolytic disease of the newborn].
    Donato H; Bacciedoni V; García C; Schvartzman G; Vain N
    Arch Argent Pediatr; 2009 Apr; 107(2):119-25. PubMed ID: 19452083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.